Liquidia: Ruling Reinforces Clear Path for FDA to Issue Final Decision on Amended NDA for Yutrepia to Treat Both PAH and PH-ILD >LQDA
Liquidia: Ruling Reinforces Clear Path for FDA to Issue Final Decision on Amended NDA for Yutrepia to Treat Both PAH and PH-ILD >LQDA
liquidia:裁决加强了FDA发布修订的Yutrepia新药申请的定论,用于治疗PAH和PH-ILD。 >LQDA
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册